Getting evidence to prescribers and patients or how to make EBM a reality

Studies in Health Technology and Informatics

Volumn 95, Issue , 2003, Pages 554-559

  Boissel, Jean Pierre ^a   Cucherat, Michel ^a   Amsallem, Emmanuel ^a   Nony, Patrice ^a   Fardeheb, Malik ^a   Manzi, Wilmondes ^a   Haugh, Margaret C ^b  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

Evidence Based Medicine; Internet; medical decision making; Telemedicine; therapeutic information

Indexed keywords

BIOINFORMATICS; DECISION MAKING; INTERNET; MEDICINE; TELEMEDICINE;

EVIDENCE-BASED MEDICINE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PROCESS-BASED; THERAPEUTIC INFORMATION;

MEDICAL INFORMATION SYSTEMS;

EID: 4344677415     PISSN: 09269630     EISSN: 18798365     Source Type: Book Series    
DOI: 10.3233/978-1-60750-939-4-554     Document Type: Conference Paper

References (32)

1. Smith R. What clinical information do doctors need ? BMJ 1996; 313: 1062-1068
2. Boissel JP. Impact of controlled clinical trials on the practice of medicine. Controlled Clin Trials 1989; 10: 120S-134S
3. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness ? Ann Int Med 1992; 117: 916-21
4. Bobbio M, Demichelis B, Giustetto G. Completeness of reporting trial results: effect on physicians' willingness'to prescribe. Lancet 1994; 343: 1209-11
5. Forrow L, Taylor WC, Arnold RM. Absolute relative: How research results are summarized can affect treatment decisions. Am J Med 1992; 92: 121-4
6. Figon G, Boissel JP, Peyrieux JC, and the GEP (Groupe d'Etude de la Prescription). Doctors' perception of pertinent information; results of a survey of a random sample of French general practioners. Eur J Clin Pharmacol 1992; 4: 113-6
7. Cialdella P, Figon G, Haugh MC, Boissel JP. Prescription intentions in relation to therapeutic information: A study of 117 French general practioners. Soc Sci &Med 1991; 33: 1263-1274
8. Evidence-Based Medicine Working Group. Evidence-based medicine, a new approach to teaching the practice of medicine. JAMA 1992; 268: 2420-5
9. Boissel JP, on behalf of the Validata Group. The Validata Group : A computerized system to deliver validated information to prescribers. In Advances in Medical Informatics, J. Noothoven van Goor and J.P. Christensen, Eds, IOS Press, p. 349-357, 1992
10. Boissel JP, Ferry S, Gallois P. Use of sales statistics for evaluating prescription rationale. TIPS 1983; 4: 401-4
11. Dickersin K, Chan S, Chalmers TC, Sacks HS, Smith H. Publication bias and clinical trials. Controlled Clin Trials 1987; 8: 343-53
12. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1992; 305: 15-9
13. Boissel JP, Gueyffier F, Haugh MC. Response to "Inclusion of women and minorities in clinical trials and the NIH revitalization act of 1993. the perspective of NIH clinical trialists". Controlled Clin Trials 1995; 16: 286-8
14. Bossard N, Boissel JP, Duru G. La hiérarchisation selon le niveau de preuve des données sources, avant leur intégration dans une synthèse, en matière d'efficacité thérapeutique. Thérapie 1996 ; 51 : 261-4
15. Darmoni SJ, Haugh M, Lukacs B, Boissel JP. Level of evidence should be gold standard BMJ 2001; 322: 1366
16. Covell DG, Uman GC, Manning PR. Information needs in office practice : Are they being met ? Ann Int Med 1985 ; 103 : 596-9
17. Ely JW, Osheroff JA, Ebell MH, Bergus GR, Levy BT, Chambliss ML, Evans ER. Analysis of questions asked by familiy doctors regarding patient care. BMJ 1999; 319: 358-61
18. Esper C, personal communication, Centre de Droit JuriSanté du CNEH, 1999
19. International Collaborative Group on Clinical trial Registries. Position paper and consensus recommendations on clinical trial registries. Clinical Trials &Meta-Analysis 1993; 28: 255-66
20. Moher D, Jadad AR, Nicol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: A annoted bibliography of scales and checklists. Controlled Clin Trials 1995; 16: 62-73
21. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-Analysis. JAMA 1999; 282: 1054-9
22. Stewart LA, Clarke MJ, on behalf of the Cochrane Working Group on Meta-Analysis Using Individual Patient Data. Practical methodology of meta-Analyses (overviews) using updated individual patients data. Stat Med 1995;14:2057-79
23. Boissel JP, Collet JP, Lièvre M, Girard P. An effect model for the assessment of drug benefit: example of antiarrhythmic drugs in postmyocardial infarction patients. J Cardiovasc Pharmacol 1993 ; 22 : 356-63
24. Collet JP, Boissel JP and the VALIDATA Group. Sick population-treated population : The need for a better definition. Ear J Clin Pharmacol 1991 ; 41 : 489-491
25. Boissel JP, Leizorovicz A, Picolet H, Ducruet T, and the APSI investigators. Efficacy of Acebutolol after acute myocardial infarction (The APSI Trial). Am J Cardiol 1990;66:24C-31C
26. Boissel JP, Gueyffier F, Haugh MC. Response to "Inclusion of women and minorities in clinical trials and the NIH revitalization act of 1993\-The perspective of NIH clinical trialists". Controlled Clin Trials 1995;16:286-8
27. Glasziou PP, Irwig LM, An evidence based approach to individualising treatment. BMJ 1995; 311: 1356-1359
28. Boissel JP. Therapeutic objectives. Evidence-Based Cardiovasc Med 1999; 3: 1
29. Boissel JP. Individualizing aspirin therapy for prevention of cardiovascular events. JAMA 1998; 280: 1949-50
30. Boissel JP. Europe: computerised information for prescribers. Lancet 1991; 338: 1513-4
31. Bero L, Rennie D. The Cochrane Collaboration; preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA 1995; 274: 1935-8
32. Strang WN, Cucherat M, Yzèbe D, Boissel JP. Trial summary sofware. Comp Methods Prog Biomed 2000; 61: 49-60